Page 2 - Type 2 Diabetes

Inflammation control in diabetics may cure depression, methods vary: Study

An analysis has revealed that addressing inflammation in diabetes can help determine success in treating depression in a group of patients. However, there are differences in outcomes between type 1 and type 2 diabetes, researchers said. While type 2 diabetes is a metabolic condition marked by an inability to manage blood sugar, type 1 diabetes is an autoimmune disorder in which the body's immune system mistakenly attacks and damages insulin-producing cells in the pancreas. "People with type 2 diabetes and high inflammation levels possibly respond particularly well to a change in depressive cognitions through cognitive behavioural therapy. People with type 1 diabetes and high inflammation levels, on the other hand, could benefit more from anti-inflammatory drug therapies," said author Norbert Hermanns from the Research Institute of the Diabetes Academy Mergentheim (FIDAM), Germany. Findings published in the journal Diabetologia could help develop customised treatment plans for ...

Not just neck pain: How longer screen time is quietly damaging your health

As digital dependency grows, experts warn that prolonged screen time is taking a toll on posture, sleep, and overall health, with many of its effects deeply interconnected

Kitchen to bloodstream: 'Forever chemicals' may raise your diabetes risk

Mount Sinai findings link PFAS exposure to type 2 diabetes as the global numbers continue to surge at alarming levels

Diabetes myths vs facts: 15 health risks you may be unknowingly taking

Fact-Check Friday: From the belief that fruits are bad to blaming sugar alone, doctors bust 15 widespread diabetes myths and offer clear, science-backed facts for better care

Why jamun seed powder is called a superfood for managing diabetes

Jamun seed powder contains jamboline and jambosine that help regulate blood sugar, support pancreatic function, and may aid in diabetes prevention if used correctly

Novo Nordisk to launch weight-loss drug Wegovy in India ahead of schedule

Amid rising demand and Eli Lilly's Mounjaro launch, Novo Nordisk is advancing plans to introduce its obesity drug Wegovy in the Indian market

Can weight-loss drugs like Ozempic help prevent cancer? New study says yes

New research suggests GLP-1 drugs like Ozempic, Wegovy, Mounjaro may lower the risk of several obesity-related cancers, even matching surgery in preventive benefits

Insulin's century-old legacy still stands tall amid new diabetes drugs

Despite the rise of GLP-1s and oral therapies, insulin remains vital for millions, particularly those with type 1 diabetes and other insulin-dependent conditions

Morepen Labs shares skyrocket 12% on rolling out 'Empamore'; details here

The uptick in the Morepen Labs share came after the company announced that it has rolled out 'Empamore.'

How fried and processed foods are fuelling India's diabetes epidemic

Indian diets, traditionally rich in whole grains, fruits, and vegetables, have shifted towards processed, fried, and sugar-laden foods, according to a recent government-backed study

Late-night sleepers face 50% greater risk of developing Type 2 diabetes

Staying up late increases Type 2 diabetes risk by nearly 50 per cent and is associated with higher BMI, larger waist circumference, and more visceral and liver fat

All you need to know about Type 1.5 diabetes, a mix of type 1 and type 2

Also known as latent autoimmune diabetes in adults (LADA), type 1.5 diabetes has features of both type 1 and type 2 diabetes

Can diabetes be cured? Chinese doctors claim breakthrough with cell therapy

A 59-year-old man with type 2 diabetes received an innovative cell transplant and has been insulin-free and off medication for 33 months, offering hope to other diabetes patients

Sun Pharma, Bayer partner for diabetes-linked kidney disease medicine

Diabetes is an epidemic in India, with nearly 100 million Indians suffering from it. Diabetes has also been identified as the leading cause of chronic kidney disease in India

17% below age of 45 don't get health cover because of uncontrolled diabetes

Diabetes is a condition wherein the insulin level of a human body drops to such an extent where the blood sugar level simply cannot be managed naturally

Approx 1 person in 20 is diabetic, 3-5% of new cases linked to Covid: Study

The findings, published in JAMA Network Open, showed that men were more likely to develop diabetes than women

Drinking tea in moderation may reduce risk of type 2 diabetes: Study

Research on over 1 million people from eight countries discovered that moderate use of black, green, or Oolong tea is linked to a lower risk of getting type 2 diabetes.

Covid-19 infection increases risk of Type 2 diabetes: Study

Previous studies have shown that the human pancreas can also be a target of SARS-CoV-2, the virus causing Covid

Zydus Healthcare launches anti-diabetic Dapagliflozin drug at cheap prices

The company has launched its Dapagliflozin tablets in the strengths of 10 mg and 5 mg priced at ₹17 and ₹14

Alembic Pharma gets tentative nod from USFDA for diabetes management drug

The product is therapeutically equivalent to Synjardy tablets of Boehringer Ingelheim Pharmaceuticals, Inc